Benchmark analyst Bill Sutherland maintains Cross Country Healthcare (NASDAQ:CCRN) with a Buy and lowers the price target from $21 to $19.
Benchmark Maintains Buy on Cross Country Healthcare, Lowers Price Target to $19
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.